Evoke Pharma (EVOK) Misses Q1 EPS by 51c

Evoke Pharma (NASDAQ: EVOK) reported Q1 EPS of ($0.51). Revenue for the quarter came in at $3.1 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• HP unveils two new OmniBook laptops powered by Nvidia RTX Spark
• DoJ antitrust division was instructed earlier this week to pause all work with the Canadian government - WSJ